Sky serves as PwC’s US Pharmaceutical and Life Sciences Deals Leader. With over 15 years serving the sector, Sky has supported clients with their inorganic growth strategies across both acquisitions and divestitures. He currently leads a sector deals team that provides support throughout the deal process, creating value through market assessments, commercial evaluation, cross functional diligence, and operational integration and separation.
4:00 PM - 5:00 PM (EST)
Tuesday, February 16